Anshu Marathe is an accomplished professional in the field of pharmacology and drug development, currently serving as Executive Director of Quantitative Pharmacology & Pharmacometrics-Immuno/Oncology at Merck since April 2024. Prior to this role, Anshu held the position of Director of PK Sciences (Clinical Pharmacology) at Novartis from July 2019 to April 2024. Anshu's extensive experience includes leadership roles at the FDA from January 2009 to July 2019, where responsibilities encompassed Clinical Pharmacology Team Leader and Scientific Lead for Biosimilar Drug Development. Anshu began a career in academia as a Post-doctoral Fellow in the Department of Pharmaceutical Sciences at the University at Buffalo from January 2007 to January 2009. Anshu earned a Ph.D. in Chemical and Biological Engineering from the University at Buffalo in January 2007, followed by a Post-doctoral Fellowship in Pharmaceutical Sciences at the same institution.
This person is not in any teams
This person is not in any offices